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1. Introduction 
Adolescent population and health of 
adolescents is a very special issue and is focus 
of attention globally for various reasons. 
Adolescence is an important transition in an 
individual's life. Turmoil which one experiences 
in this period-has greater effects onto the 
behavioural aspects of an individual. If one 
divides the whole stream of an individual's life 
into certain urbitrary segments, then 
adolescence is that period of life which lies 
between childhood and adulthood (1-4). 
Adolescence is characterised by a strong 
tendency to experiment with risk behaviour. 
Why Test?  
Standard methods of adherence monitoring 
for prescribed substances, for example, self-
reporting and monitoring of symptoms or 
patient behaviors, are unreliable for controlled 
substances. 
Whom to Test?  
Practice guidelines on pain management 
intended to promote safe and competent opioid 
prescribing recommend various measures to 
mitigate risk including UDT, but some 
disagreement persists on who should be 
subjected to routine UDT and its frequency. 
Two types of drug testing assays are 
available: qualitative tests usually used for 
screening and quantitative tests used for 
confirmation. Qualitative tests are point-of-care 
tests and home drug test kits. They are easy to 
perform, relatively inexpensive, and use 
immunoassays, such as enzyme-linked 
immunoassay or radioimmunoassay, that give 
instant positive or negative results. Although 
they are sensitive and function well as screening 
tests, they are susceptible to cross-reactions, 
resulting in false-positive results, which limit 
their specificity. Some laboratories use 
qualitative tests as a “screening procedure”; in 
this method, negative test results are discarded, 
and only positive test results are run through 
more expensive confirmatory testing, although 
the 2-step procedure has become less common 
as the cost of confirmatory testing has 
decreased. Confirmatory tests are performed in 
laboratories and not at the point of care. Most 
laboratories use a combination of gas 
chromatography and mass spectrometry and can 
positively identify a substance and generate 
quantitative concentrations (5-7). 
Urine screening can provide an indication 
that someone has consumed drugs at some point 
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before sampling. Most drugs typically have a 
detection window of up to 48 hours (Table). 
This may be shorter for some drugs which are 
eliminated relatively quickly from the body 
such as alcohol or gamma hydroxybutyrate. 
Drugs such as diazepam and cannabis can 
persist in urine for days or even weeks and so 
can be detected for longer periods. The 
frequency of drug consumption will also have 
an impact on the effectiveness of urine 
screening. Acute or once-off use, as in the case 
of drug-facilitated crime where a drug is used to 
render someone incapacitated, is more difficult 
to detect and may challenge the sensitivity of 
urine screening. People who use drugs more 
regularly will typically have higher 
concentrations of drugs in their urine leading to 
easier detection with possibly longer timeframes 
(8-9). 
In chronic users, drugs of abuse can be 
detected in urine for approximately one week 
after last use, and in extreme cases even longer 
in cocaine (22 days) and cannabis users (up to 
three months). Urine testing will not show when 
a drug was used, or how much. Importantly, a 
positive drug result cannot infer impairment at 
the time the urine was collected (10-12). Most 
commonly used drug screening tests involve 
immunoassay techniques (13). These range 
from so-called bedside or point-of-care testing 
to more sophisticated laboratory-based 
immunological tests. Immunoassay can provide 
fast and reliable results, however the results 
must be interpreted with caution. 
Table 1 Advantages and disadvantages of urine used for drug testing. 
Advantages Disadvantages 
 Available in sufficient quantities 
 Higher concentrations of parent drugs and/or 
metabolites than in blood 
 Availability of point-of-care tests (POCTs) 
 Well-researched testing techniques 
 Short to intermediate window of detection 
 Easy to adulterate or substitute 
 May require observed collection 
 Some individuals experience “shy bladder” 
syndrome and cannot produce a specimen 
 
2. Materials and Methods 
In hospital or pathology laboratories the 
emphasis is typically on drugs of abuse, 
screening either for compliance to (e.g. 
methadone) or abstinence from (e.g. cannabis) 
particular substances. Hospital screening can 
also give the clinician additional help in the 
differential diagnosis and treatment of a patient, 
but the availability of toxicological analyses 
varies between hospitals. 
Most commonly used drug screening tests 
involve immunoassay techniques. These range 
from so-called bedside or point-of-care testing 
to more sophisticated laboratory-based 
immunological tests. Immunoassay can provide 
fast and reliable results, however the results 
must be interpreted with caution. 
Sample and settings 
We approached all subjects aged 12 to 18 
years and Individual schools and classes were 
selected randomly 
Forensic Urine Drug Testing  
In forensic drug testing, results are meant to 
stand up to legal challenges and meet the rules 
of evidence in legal proceedings. Chain-of-
custody procedures, secure storage of samples, 
and stringent method validations are utilized 
with the aim of minimizing or eliminating false 
positive results, and rigorous laboratory 
certification programs are used to assure 
quality. The personnel running the tests in a 
forensic UDT laboratory usually have training 
in chemistry or forensic science and they 
understand chain-of-custody and medicolegal 
requirements. 
3. Results and Discussion 
The valid detection period for drug exposure 
varies depending on the disposition 
characteristics of the drug, dose, and frequency 
of use. Specific characteristics of a urine sample 
include its appearance, temperature within 4 
minutes of voiding, pH, creatinine 
concentration, and specific gravity. The color of 
urine is based on the concentration of its 
constituents and can vary based on medications, 
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foods, or disease states; excess hydration can 
cause it to appear colorless. Concentrated urine 
specimens are usually more reliable than dilute 
specimens. 
Table 2 Detection of drug in Urine 
 
 
Most drugs of interest are first detected by 
simple immunoassays. These are broad 
screening tests that are quick, often cheap and 
effective for showing a positive or negative 
result. However, as with all screening tests there 
are limitations to the degree of interpretation 
that can be inferred from the result. The 
limitations of immunoassay techniques include 
false positives as well as false negative results. 
Benzodiazepines: Variability in 
immunoassay cross-reactivity also applies to 
benzodiazepines. While many benzodiazepines 
are generally detected by immunoassay, not all 
benzodiazepines are equally detectable by all 
reagents. Clinicians should carefully interpret 
the presence or absence of the benzodiazepine 
class when assessing treatment adherence. 
In most instances it is useful to have a 
private conversation with the adolescent to 
clarify interpretation of the drug test result. 
Simply sharing that the drug test yielded an 
“unexpected result” without revealing specific 
details may set the stage for an honest 
conversation about substance use, and at times, 
patients will reveal use of substances that 
were not detected by the test. If the patient gives 
a history that is consistent with the drug 
test results the conversation can move on to a 
discussion of next steps – which could include 
changes to the treatment plan. Sharing drug test 
results together with a plan may facilitate a 
positive conversation. 
When a drug test result is dilute or 
otherwise ambiguous a clinical interview may 
be helpful. Starting with a simple statement 
about an “unexpected test result” without 
revealing all of the details can serve as an open-
ended way of beginning the conversation. If a 
patient does not report substance use the 
clinician can review methods for reducing the 
chance of a dilute specimen – by providing a 
first morning urine if possible, or if not, limiting 
water intake in the hour prior to giving a 
sample. Repeat testing may be useful. 
Confirmation tests are usually required for 
medicolegal purposes when drug testing is used 
in the workplace or for family custody disputes 
in which parents are allegedly using drugs at 
home in the presence of children. An initial 
urinary screening test must be confirmed for 
evidence of drug use. Confirmatory testing is 
more sensitive and specific than screening tests 
and confirms the drug of interest as opposed to 
the drug class. 
IA is non-specific and cross-reactions can 
occur. As an example, quinolone antibiotics can 
cross react with an opioid panel yielding a false 
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positive test result. To eliminate this type 
oferror, IA tests should be confirmed with a 
more definitive chromatographic test (e.g., 
GCMS), particularly if a test result is 
unexpected and does not correlate with a 
patient’s history. 
The evolution of oral-fluid testing (saliva) 
both from a policy and technology viewpoint 
has grown rapidly in recent years. This testing 
has been used primarily to test drivers for illicit 
drugs (amphetamines and cannabis) and is now 
being used in the workplace. 
Saliva is easier and safer to collect than 
urine. Unlike urine, not all drugs are easily 
detectable in oral fluid, either because of the 
low concentrations or the short time that drugs 
are present in saliva. The detection of a drug in 
oral fluid is normally associated with recent use 
(up to 24 hours) as the drugs can be related to 
blood or plasma concentrations and therefore 
physiological effect. This cannot be inferred 
from urine as the concentration in urine can 
only be related to previous consumption and not 
any effect of the drug. 
4. Conclusion 
Adolescents need to be treated as a distinct 
segment of our population and it is important to 
realize and address their health and lifestyle 
problems. Inadequate sleep, depression and 
smoking were the leading unhealthy behaviours 
among the respondents. Families can play an 
important role to help these adolescents live a 
healthier life. Because substance-use disorders 
are common, UDT should be considered a core 
tool in primary care. The clinician can use a 
discordant UDT result to motivate patient 
behavior change. However, testing without an 
appropriate strategy for interpreting results can 
do harm. A working relationship with the 
testing laboratory or test kit provider is essential 
to accurately interpret UDT results. Most 
importantly, a health care professional should 
strive for a relationship of mutual honesty and 
trust with the patient when using UDT in his or 
her clinical practice. Therefore, the use of UDT 
should be consensual, be designed to help 
patients, and assist health care professionals to 
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